Europe
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Pfizer and BioNTech updated their development program, with plans to launch clinical trials in the U.S. and Europe across multiple sites by the end of April.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 9, 2020.
Biopharma companies from across the globe provide updates to their business operations and pipelines.
Many people have lost their jobs and, as a result, their insurance. That can be daunting enough, but for those who need life-saving drugs such as insulin, the situation is magnified.
AstraZeneca made an announcement describing its internal and partnering efforts to battle COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.
As the pandemic progresses, researchers are attacking the virus from every angle, and also learning more and more about how and why the virus affects who it does.
“We are excited to partner with Roche’s strong research and development team,” said Michael Gilman, Arrakis’ chief executive officer.
“It’s especially cruel when cancer affects such small children, so it is encouraging that this study offers some hope for very young patients and their families,” said Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London.
The United States leads the world in biotech innovation, but does it also lead the world in the development of COVID-19 diagnostics, vaccines and therapeutics?
PRESS RELEASES